id	name	code	description	create_date	active
1	APAL2020SC	APAL2020SC	APAL2020SC - description		1
2	SELCLAX	SELCLAX	SELCLAX - description		1
3	VENAML	VENAML	VENAML - description		1
4	PEPN1812	PEPN1812	PEPN1812 - description		1
5	T2016-003	T2016-003	T2016-003 - description		1
6	2020-0484	2020-0484	2020-0484 - description		1
7	834675	834675	834675 - description		1
8	APAL2020D	APAL2020D	A study to evaluate if the randomized addition of venetoclax to a chemotherapy backbone (fludarabine/cytarabine/gemtuzumab ozogamicin [GO]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse who are unable to receive additional anthracyclines, or in 2nd relapse.		1
